Insider Transactions Reported by 12 Insiders of Glucotrack, Inc.

Symbol: GCTK on Nasdaq
Location: Rutherford, NJ

Key facts

GCTK - Glucotrack, Inc. has 12 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are available for direct filing-level review.

Change

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Research use

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 23 May 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

Glucotrack, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Valuation	Report Date
John Ballantyne	Director, 10%+ Owner	$85,179,227	Mixed	16 Aug 2024
John A. Ballantyne Revocable Living Trust dated 08/01/2017	10%+ Owner	$85,051,321	Mixed	30 Jul 2024
Drew Sycoff	Director, 10%+ Owner	$3,718,585	Filing P/S	01 Jul 2024
Robert Fischell	Director	$63,804	Mixed	24 Aug 2021
Andrew K. Balo	Director	$22,850	Mixed	26 Mar 2025
Luis Malave	Director	$19,762	Mixed	25 Mar 2025
Allen Danzig	Director	$18,960	Mixed	04 Oct 2022
Erin Catherine Carter	Director	$10,460	Mixed	25 Mar 2025
Paul Goode	Chief Executive Officer, Director	$1,650	Mixed	25 Mar 2025
Brendel Victoria Carr	Director		Mixed	22 May 2025
Peter C. Wulff	Chief Financial Officer		Mixed	28 Jan 2025
James S. Cardwell	Chief Financial Officer		Mixed	11 Oct 2023

Top shareholders of Glucotrack, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARMISTICE CAPITAL, LLC	13D/G	—	5%	102,115	$89,861	+$915	31 Mar 2026	13D/G
SABBY MANAGEMENT, LLC	13D/G	—	4.9%	647,055	$241,352	$0	31 Dec 2024	13D/G
Ikarian Capital, LLC	13D/G 13F	Company	4.5%	45,830	$175,071	$0	31 Dec 2025	13D/G 13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.3%	47,001	$30,550	—	31 Mar 2026	13F
HRT FINANCIAL LP	13F	Company	2%	40,631	$26,000	—	31 Mar 2026	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.66%	13,525	$8,791	—	31 Mar 2026	13F
VANGUARD FIDUCIARY TRUST CO	13F	Company	0.23%	4,722	$3,069	—	31 Mar 2026	13F
ALERUS FINANCIAL NA	13F	Company	0.2%	4,000	$2,600	—	31 Mar 2026	13F
Tower Research Capital LLC (TRC)	13F	Company	0.17%	3,442	$2,237	—	31 Mar 2026	13F
UBS Group AG	13F	Company	0.03%	702	$456	—	31 Mar 2026	13F
NFSG Corp	13F	Company	0%	34	$22	—	31 Mar 2026	13F
SBI Securities Co., Ltd.	13F	Company	0%	9	$6	—	31 Mar 2026	13F
MORGAN STANLEY	13F	Company	0%	1	$1	—	31 Mar 2026	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	1	$1	—	31 Mar 2026	13F
John Ballantyne	3/4/5	Director, 10%+ Owner	— mixed-class rows	2,939,013 mixed-class rows	$85,179,227	—	16 Aug 2024	3/4/5
John A. Ballantyne Revocable Living Trust dated 08/01/2017	3/4/5	10%+ Owner	— mixed-class rows	2,934,887 mixed-class rows	$85,051,321	—	30 Jul 2024	3/4/5
Drew Sycoff	3/4/5	Director, 10%+ Owner	— mixed-class rows	3,089,258 mixed-class rows	$3,718,585	—	01 Jul 2024	3/4/5
Robert Fischell	3/4/5	Director	— class O/S missing	2,045	$63,804	—	24 Aug 2021	3/4/5
Andrew K. Balo	3/4/5	Director	— mixed-class rows	8,747 mixed-class rows	$22,850	—	26 Mar 2025	3/4/5
Luis Malave	3/4/5	Director	— mixed-class rows	14,999 mixed-class rows	$19,762	—	25 Mar 2025	3/4/5
Allen Danzig	3/4/5	Director	— class O/S missing	1,922	$18,960	—	04 Oct 2022	3/4/5
Erin Catherine Carter	3/4/5	Director	— mixed-class rows	8,281 mixed-class rows	$10,460	—	25 Mar 2025	3/4/5
Paul Goode	3/4/5	Chief Executive Officer, Director	— mixed-class rows	6,512 mixed-class rows	$1,650	—	25 Mar 2025	3/4/5

Recent Insider Transactions by Companies or Individuals for Glucotrack, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Shares	Shares Owned	Date	Ownership
Andrew K. Balo	GCTK	Common Stock, par value $0.001 per share	Award	37.7%	1,285	4,692	03 Oct 2025	Direct
Andrew K. Balo	GCTK	Stock option (right to buy)	Award		4,055	4,055	03 Oct 2025	Direct
Luis Malave	GCTK	Common Stock, par value $0.001 per share	Award	12.9%	463	4,058	03 Oct 2025	Direct
Luis Malave	GCTK	Stock option (right to buy)	Award		4,055	4,055	03 Oct 2025	Direct
Erin Catherine Carter	GCTK	Common Stock, par value $0.001 per share	Award	21.9%	386	2,148	03 Oct 2025	Direct
Erin Catherine Carter	GCTK	Stock option (right to buy)	Award		4,055	4,055	03 Oct 2025	Direct
Andrew K. Balo	GCTK	Common Stock, par value $0.001 per share	Award	4442.7%	3,332	3,407	11 Jul 2025	Direct
Luis Malave	GCTK	Common Stock, par value $0.001 per share	Award	50.1%	1,200	3,595	11 Jul 2025	Direct
Erin Catherine Carter	GCTK	Common Stock, par value $0.001 per share	Award	131.2%	1,000	1,762	11 Jul 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.